Abiopharma

🔍 Huffman Steve Ladd (Director)

Company: Reddit, Inc. (RDDT)

Report Date: 2026-05-05

Detailed Transactions and Holdings:

• Acquired 18,000 shares of Class A Common Stock at $25.29 per share (Direct)
  Date: 2026-05-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 429,195.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,200 shares of Class A Common Stock at $168.53 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 427,995.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 1,200 shares of Class A Common Stock at $169.76 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 426,795.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 3,701 shares of Class A Common Stock at $170.9 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 423,094.00 | transaction_form_type: 4 | Footnotes: F1, F4
• Sold 7,249 shares of Class A Common Stock at $171.9 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 415,845.00 | transaction_form_type: 4 | Footnotes: F1, F5
• Sold 1,850 shares of Class A Common Stock at $172.82 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 413,995.00 | transaction_form_type: 4 | Footnotes: F1, F6
• Sold 1,700 shares of Class A Common Stock at $173.78 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 412,295.00 | transaction_form_type: 4 | Footnotes: F1, F7
• Sold 700 shares of Class A Common Stock at $174.71 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 411,595.00 | transaction_form_type: 4 | Footnotes: F1, F8
• Sold 300 shares of Class A Common Stock at $175.92 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 411,295.00 | transaction_form_type: 4 | Footnotes: F1, F9
• Sold 100 shares of Class A Common Stock at $176.81 per share (Direct)
  Date: 2026-05-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 411,195.00 | transaction_form_type: 4 | Footnotes: F1, F10
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-05 | Code: H | nature_of_ownership: EVS Trust - I | shares_owned_after: 68,966.00 | Footnotes: F11
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-05 | Code: H | nature_of_ownership: MLH Trust - I | shares_owned_after: 6,897.00 | Footnotes: F11
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-05-05 | Code: H | nature_of_ownership: JDI Trust - I | shares_owned_after: 6,897.00 | Footnotes: F11
• Sold 18,000 shares of Stock Option (Right to Buy) at $25.29 per share (Derivative)
  Date: 2026-05-05 | Code: M | Expires: 2033-12-25 | equity_swap_involved: 0 | shares_owned_after: 1,189,255.00 | transaction_form_type: 4 | Footnotes: F12

Footnotes:

• F1: This transaction reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2025.
• F2: The sales were executed in multiple trades at prices ranging from $168.04 to $169.03. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price within the ranges set forth in footnotes 2 to 10 to this Form 4.
• F3: The sales were executed in multiple trades at prices ranging from $169.26 to $170.20.
• F4: The sales were executed in multiple trades at prices ranging from $170.41 to $171.40.
• F5: The sales were executed in multiple trades at prices ranging from $171.41 to $172.39.
• F6: The sales were executed in multiple trades at prices ranging from $172.41 to $173.35.
• F7: The sales were executed in multiple trades at prices ranging from $173.47 to $174.21.
• F8: The sales were executed in multiple trades at prices ranging from $174.48 to $175.06.
• F9: The sales were executed in multiple trades at prices ranging from $175.81 to $176.15.
• F10: The sales were executed in multiple trades at $176.81.
• F11: The securities are directly held by a grantor retained annuity trust, of which the Reporting Person is sole trustee and beneficiary.
• F12: The option vests over five years on each quarterly anniversary of December 25, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.